Cellics Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $7M

  • Investors
  • 2

Cellics Therapeutics General Information

Description

Developer of nanosponge technology designed to address serious diseases with a high unmet medical need. The company's technology utilizes a nanosponge mechanism for the treatment of animal venoms and rare diseases that are caused by virulent factors due to attacks on red blood cells, enabling physicians to treat their patients in an enhanced way.

Contact Information

Website
www.cellics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11588 Sorrento Valley Road
  • Suite 20
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Corporate Office
  • 11588 Sorrento Valley Road
  • Suite 20
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellics Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 17-Feb-2022 $7M Completed Clinical Trials - Phase 1
5. Grant 21-Oct-2020 Completed Pre-Clinical Trials
4. Later Stage VC (Series A3) 08-Jun-2020 Completed Pre-Clinical Trials
3. Early Stage VC 20-Apr-2018 Completed Pre-Clinical Trials
2. Early Stage VC (Series A1) $2.5M $8.5M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 21-Apr-2017 $6M $6M Completed Pre-Clinical Trials
To view Cellics Therapeutics’s complete valuation and funding history, request access »

Cellics Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A3
Series A2
Series A1 1,006,239 $0.001000 8% $2.48 $2.48 1x $2.48 4.28%
Series A 4,900,000 $0.001000 8% $1.22 $1.22 1x $1.22 20.83%
To view Cellics Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellics Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nanosponge technology designed to address serious diseases with a high unmet medical need. The company's te
Drug Discovery
San Diego, CA
21 As of 2026

Cambridge, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cellics Therapeutics Competitors (2)

One of Cellics Therapeutics’s 2 competitors is GentiBio, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GentiBio Venture Capital-Backed Cambridge, MA
TRexBio Formerly VC-backed South San Francisco, CA
You’re viewing 2 of 2 competitors. Get the full list »

Cellics Therapeutics Patents

Cellics Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019388869-A1 Nanoparticles containing cellular membrane and uses thereof Active 26-Nov-2018
AU-2019388869-B2 Nanoparticles containing cellular membrane and uses thereof Active 26-Nov-2018
CA-3120860-A1 Nanoparticles containing cellular membrane and uses thereof Pending 26-Nov-2018
EP-3886870-A1 Nanoparticles containing cellular membrane and uses thereof Pending 26-Nov-2018
EP-3886870-A4 Nanoparticles containing cellular membrane and uses thereof Pending 26-Nov-2018 A61K9/5068
To view Cellics Therapeutics’s complete patent history, request access »

Cellics Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellics Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
CARB-X University
CASH Capital Venture Capital Minority
To view Cellics Therapeutics’s complete investors history, request access »

Cellics Therapeutics FAQs

  • When was Cellics Therapeutics founded?

    Cellics Therapeutics was founded in 2014.

  • Where is Cellics Therapeutics headquartered?

    Cellics Therapeutics is headquartered in San Diego, CA.

  • What is the size of Cellics Therapeutics?

    Cellics Therapeutics has 21 total employees.

  • What industry is Cellics Therapeutics in?

    Cellics Therapeutics’s primary industry is Drug Discovery.

  • Is Cellics Therapeutics a private or public company?

    Cellics Therapeutics is a Private company.

  • What is the current valuation of Cellics Therapeutics?

    The current valuation of Cellics Therapeutics is .

  • What is Cellics Therapeutics’s current revenue?

    The current revenue for Cellics Therapeutics is .

  • How much funding has Cellics Therapeutics raised over time?

    Cellics Therapeutics has raised $25.5M.

  • Who are Cellics Therapeutics’s investors?

    CARB-X and CASH Capital have invested in Cellics Therapeutics.

  • Who are Cellics Therapeutics’s competitors?

    GentiBio and TRexBio are competitors of Cellics Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process